Sheng H, Shao J, Hooton E B, Tsujii M, DuBois R N, Beauchamp R D
Department of Surgery, Vanderbilt Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2279, USA.
Cell Growth Differ. 1997 Apr;8(4):463-70.
Rat intestinal epithelial cells (RIE-1) permanently transfected with the prostaglandin endoperoxide synthase 2 (also referred to as cyclooxygenase-2; COX-2) gene exhibit decreased cyclin D1 levels, decreased cdk4-associated kinase activity, and delayed G1 cell cycle progression, which represents a phenotype similar to that which follows transforming growth factor beta (TGF-beta) treatment. In the current study, we have found that addition of TGF-beta 1 to the parental RIE-1 cells (designated RIE-P) caused a rapid induction of COX-2 mRNA and protein. COX-2 protein levels progressively increased and reached peak levels 6 h after TGF-beta 1 addition. Cyclin D1 was decreased by 74% at 6 h and was undetectable 24 h after addition of TGF-beta 1. In RIE cells transfected with the COX-2 antisense expression vector (RIE-AS cells), TGF-beta 1 induction of COX-2 protein was reduced greater than 90%. Addition of TGF-beta 1 did not reduce the abundant cyclin D1 protein expression in the RIE-AS cells, unlike the effect in RIE-P cells. TGF-beta 1 treatment reduced peak [3H]thymidine incorporation by 60% and delayed G1/S-phase transition by at least 4 h in the RIE-P cells. In contrast, S-phase entry occurred at 16 h in RIE-AS cells and was not altered by TGF-beta 1 treatment. Restoration of cyclin D1 expression by transfection of the cyclin D1 cDNA under transcriptional control of the cytomegalovirus promoter/enhancer in the COX-2-overexpressing (RIE-S) cells decreased the time required for S-phase entry by at least 4 h and increased the peak level of [3H]thymidine incorporation. Taken together, the results demonstrate that TGF-beta 1 strongly induces COX-2 at both the mRNA and protein levels and suggest that this induction of COX-2 is involved in the down-regulation of cyclin D1 and inhibition of cell growth caused by TGF-beta 1 in rat intestinal epithelial cells.
用前列腺素内过氧化物合酶2(也称为环氧化酶-2;COX-2)基因永久转染的大鼠肠上皮细胞(RIE-1)表现出细胞周期蛋白D1水平降低、与细胞周期蛋白依赖性激酶4(cdk4)相关的激酶活性降低以及G1期细胞周期进程延迟,这代表了一种与转化生长因子β(TGF-β)处理后相似的表型。在本研究中,我们发现向亲代RIE-1细胞(称为RIE-P)中添加TGF-β1会迅速诱导COX-2 mRNA和蛋白表达。COX-2蛋白水平逐渐升高,并在添加TGF-β1后6小时达到峰值。细胞周期蛋白D1在6小时时降低了74%,在添加TGF-β1后24小时检测不到。在用COX-2反义表达载体转染的RIE细胞(RIE-AS细胞)中,TGF-β1诱导的COX-2蛋白减少超过90%。与对RIE-P细胞的作用不同,添加TGF-β1并未降低RIE-AS细胞中丰富的细胞周期蛋白D1蛋白表达。TGF-β1处理使RIE-P细胞中[3H]胸腺嘧啶核苷掺入峰值降低60%,并使G1/S期转换延迟至少4小时。相比之下,RIE-AS细胞在16小时进入S期,且不受TGF-β1处理的影响。通过在COX-2过表达(RIE-S)细胞中用巨细胞病毒启动子/增强子转录控制转染细胞周期蛋白D1 cDNA来恢复细胞周期蛋白D1表达,使进入S期所需时间至少缩短4小时,并增加了[3H]胸腺嘧啶核苷掺入峰值。综上所述,结果表明TGF-β1在mRNA和蛋白水平上均强烈诱导COX-2,并提示这种COX-2的诱导参与了TGF-β1对大鼠肠上皮细胞中细胞周期蛋白D1的下调和细胞生长的抑制。